Showing results (1211-1220 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|July 28, 2020
Economic Burden of Metastatic Ovarian Cancer in a Commercially Insured Population: A Retrospective Cohort AnalysisLauren Chin, Ryan N Hansen, Josh J CarlsonJournal of Managed Care & Specialty Pharmacy|July 28, 2020
Effectiveness and Costs Among Rheumatoid Arthritis Patients Treated with Targeted Immunomodulators Using Real-World U.S. DataMahdi Gharaibeh, Machaon Bonafede, Donna McMorrow, et al.Journal of Managed Care & Specialty Pharmacy|July 28, 2020
A Call to Action to Track Generic Drug Quality Using Real-World Data and the FDA's Sentinel InitiativeJoshua D BrownJournal of Managed Care & Specialty Pharmacy|April 30, 2023
Burden of lipoprotein(a) for patients with atherosclerotic cardiovascular disease: A retrospective analysis from the United StatesAna F Fonseca, Hannah Byrne, Andres Laguna, et al.Journal of Managed Care & Specialty Pharmacy|January 24, 2015
Quality process measures for rheumatoid arthritis: performance from members enrolled in a national health planJoseph Tkacz, Lorie A Ellis, Roxanne Meyer, et al.Journal of Managed Care & Specialty Pharmacy|January 24, 2015
Economic burden associated with adverse events in patients with metastatic melanomaBhakti Arondekar, Suellen Curkendall, Matthew Monberg, et al.Journal of Managed Care & Specialty Pharmacy|June 26, 2020
Real-World Assessment of Health Care Costs for Patients with Metastatic Pancreatic Cancer Following Initiation of First-Line ChemotherapyAndrea Bullock, Christopher G Rowan, Nina Oestreicher, et al.Journal of Managed Care & Specialty Pharmacy|June 26, 2020
Framework for Pharmacy Services Quality Improvement-A Bridge to Cross the Quality ChasmFrederic R Curtiss, Richard N Fry, Steven G AveyJournal of Managed Care & Specialty Pharmacy|June 26, 2020
Treatment Patterns and Characteristics of Individuals Initiating High-Dose Insulin for Type 2 Diabetes MellitusJieling Chen, Radhika Nair, Mir Siadaty, et al.Journal of Managed Care & Specialty Pharmacy|June 30, 2020
The Economic Burden of End-Organ Damage Among Medicaid Patients with Sickle Cell Disease in the United States: A Population-Based Longitudinal Claims StudyAndrew Campbell, Ze Cong, Irene Agodoa, et al.Pageof 185